Notis-mcconarty Edward buys $4,428,147 stake in CVS Health Corp (CVS)

CVS Health Corp (CVS) : Notis-mcconarty Edward scooped up 210 additional shares in CVS Health Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 45,651 shares of CVS Health Corp which is valued at $4,428,147.CVS Health Corp makes up approximately 3.00% of Notis-mcconarty Edward’s portfolio.

Other Hedge Funds, Including , Fayerweather Charles reduced its stake in CVS by selling 175 shares or 0.47% in the most recent quarter. The Hedge Fund company now holds 37,445 shares of CVS which is valued at $3,632,165. CVS Health Corp makes up approx 4.93% of Fayerweather Charles’s portfolio.Thompson Siegel Walmsley boosted its stake in CVS in the latest quarter, The investment management firm added 379 additional shares and now holds a total of 15,873 shares of CVS Health Corp which is valued at $1,545,554. CVS Health Corp makes up approx 0.02% of Thompson Siegel Walmsley’s portfolio. Torch Wealth Management added CVS to its portfolio by purchasing 11,800 company shares during the most recent quarter which is valued at $1,139,290. CVS Health Corp makes up approx 0.81% of Torch Wealth Management’s portfolio.Central Bank Trust Co reduced its stake in CVS by selling 3,418 shares or 4.77% in the most recent quarter. The Hedge Fund company now holds 68,231 shares of CVS which is valued at $6,661,393. CVS Health Corp makes up approx 1.88% of Central Bank Trust Co’s portfolio.

CVS Health Corp opened for trading at $97.4 and hit $97.67 on the upside on Monday, eventually ending the session at $97.58, with a gain of 0.15% or 0.15 points. The heightened volatility saw the trading volume jump to 23,97,182 shares. Company has a market cap of $104,041 M.

On the company’s financial health, CVS Health Corp reported $1.32 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.30. The company had revenue of $43725.00 million for the quarter, compared to analysts expectations of $44281.46 million. The company’s revenue was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS.

Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Mizuho on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 111 from a previous price target of $108 .Company shares were Reiterated by Deutsche Bank on Aug 3, 2016 to “Hold”, Firm has raised the Price Target to $ 108 from a previous price target of $99 .Shares were Reiterated by Mizuho on Jun 23, 2016 to “Buy” and Lowered the Price Target to $ 108 from a previous price target of $117 .

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *